Does oxidative stress suppress thyroid hormone signaling and reduce T4-to-T3 conversion?

Oxidative stress significantly influences thyroid homeostasis by disrupting both hormone metabolism and nuclear receptor signaling. This interaction is particularly relevant in geriatric populations, where higher systemic oxidative stress is strongly associated with lower fT3/fT4 ratios and increased frailty.

Clinical and metabolic evidence

Oxidative stress impairs the peripheral conversion of thyroxine (T4) to active triiodothyronine (T3) by inhibiting type 1 and type 2 deiodinases (D1 and D2). These enzymes are selenoproteins that require thiol-containing cofactors, primarily glutathione (GSH), to return to their active, reduced state after each catalytic cycle. High levels of reactive oxygen species (ROS) deplete cellular GSH, stalling this cycle and reducing the efficiency of T3 production. Clinical data indicates that patients with compromised thiol status exhibit reduced peripheral conversion and potential resistance to thyroid hormone therapy.

Shift toward inactive metabolites

Simultaneously, oxidative stress and inflammatory cytokines (such as IL-6) upregulate type 3 deiodinase (DIO3). This enzyme diverts metabolism toward inactive forms by converting T4 into reverse T3 (rT3) instead of active T3. This metabolic shift—characterized by low fT3 and elevated rT3—is a hallmark of non-thyroidal illness syndrome (NTIS). In acute settings like sepsis, the induction of DIO3 in immune cells is directly correlated with lower systemic T3 levels and increased mortality.

Mechanistic explanations

Beyond metabolism, ROS directly interfere with thyroid hormone receptor (TR) function. Excessive oxidation disrupts the ability of TRs to bind to thyroid response elements (TREs) on DNA and impairs the recruitment of essential transcriptional coactivators. This suppresses the expression of critical target genes, such as thyroglobulin (Tg). While the Nrf2/Keap1 pathway acts as a compensatory mechanism to stabilize TR signaling, its exhaustion under chronic oxidative stress leads to significant glandular and peripheral dysfunction.

Bottom line

Oxidative stress suppresses thyroid signaling by depleting the glutathione required for T4-to-T3 conversion while upregulating DIO3 to produce inactive rT3. These metabolic shifts, combined with impaired receptor binding, drive the "low T3 syndrome" observed in aging and chronic illness.